Lv3
360 积分 2021-07-22 加入
Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis
23小时前
已完结
ABS0150 ANTI-TL1A ANTIBODY REDUCES DISEASE SYMPTOMS AND PATHOLOGICAL CHANGES IN RAT COLLAGEN-INDUCED ARTHRITIS
4天前
求助中
Ankylosing spondylitis: From pathogenesis to therapy
6天前
已完结
ELA026, a Monoclonal Antibody Targeting Signal Regulatory Protein-α/β1/γ, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naïve Malignancy-Associated Hemophagocytic Lymphohistiocytosis
8天前
已关闭
Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study
14天前
已完结
Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
20天前
已完结
A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy
1个月前
已完结
OP0299 GENAKUMAB REDUCES THE RISK OF ACUTE GOUT FLARES DURING INITIATION OF URATE-LOWERING THERAPY: A PHASE 2, RANDOMIZED, OPEN-LABEL, MULTI-CENTER, ACTIVE-CONTROLLED CLINICAL TRIAL
1个月前
已关闭
Antibody–bottlebrush prodrug conjugates for targeted cancer therapy
1个月前
已完结
Antibody–bottlebrush prodrugs pack a punch for targeted cancer therapy
1个月前
已完结
皖公网安备34019202002308
